Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents

Reports have emerged of myocarditis and pericarditis predominantly after the second dose of the coronavirus disease messenger ribonucleic acid vaccine. We describe 13 patients aged 12-17 years who presented with chest pain within 1 week after their second dose of the Pfizer vaccine and were found to...

Descripción completa

Detalles Bibliográficos
Autores principales: Schauer, Jenna, Buddhe, Sujatha, Colyer, Jessica, Sagiv, Eyal, Law, Yuk, Mallenahalli Chikkabyrappa, Sathish, Portman, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253718/
https://www.ncbi.nlm.nih.gov/pubmed/34228985
http://dx.doi.org/10.1016/j.jpeds.2021.06.083
_version_ 1783717573477531648
author Schauer, Jenna
Buddhe, Sujatha
Colyer, Jessica
Sagiv, Eyal
Law, Yuk
Mallenahalli Chikkabyrappa, Sathish
Portman, Michael A.
author_facet Schauer, Jenna
Buddhe, Sujatha
Colyer, Jessica
Sagiv, Eyal
Law, Yuk
Mallenahalli Chikkabyrappa, Sathish
Portman, Michael A.
author_sort Schauer, Jenna
collection PubMed
description Reports have emerged of myocarditis and pericarditis predominantly after the second dose of the coronavirus disease messenger ribonucleic acid vaccine. We describe 13 patients aged 12-17 years who presented with chest pain within 1 week after their second dose of the Pfizer vaccine and were found to have elevated serum troponin levels and evidence of myopericarditis.
format Online
Article
Text
id pubmed-8253718
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-82537182021-07-06 Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents Schauer, Jenna Buddhe, Sujatha Colyer, Jessica Sagiv, Eyal Law, Yuk Mallenahalli Chikkabyrappa, Sathish Portman, Michael A. J Pediatr Brief Report Reports have emerged of myocarditis and pericarditis predominantly after the second dose of the coronavirus disease messenger ribonucleic acid vaccine. We describe 13 patients aged 12-17 years who presented with chest pain within 1 week after their second dose of the Pfizer vaccine and were found to have elevated serum troponin levels and evidence of myopericarditis. Elsevier Inc. 2021-11 2021-07-03 /pmc/articles/PMC8253718/ /pubmed/34228985 http://dx.doi.org/10.1016/j.jpeds.2021.06.083 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Brief Report
Schauer, Jenna
Buddhe, Sujatha
Colyer, Jessica
Sagiv, Eyal
Law, Yuk
Mallenahalli Chikkabyrappa, Sathish
Portman, Michael A.
Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents
title Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents
title_full Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents
title_fullStr Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents
title_full_unstemmed Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents
title_short Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents
title_sort myopericarditis after the pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253718/
https://www.ncbi.nlm.nih.gov/pubmed/34228985
http://dx.doi.org/10.1016/j.jpeds.2021.06.083
work_keys_str_mv AT schauerjenna myopericarditisafterthepfizermessengerribonucleicacidcoronavirusdiseasevaccineinadolescents
AT buddhesujatha myopericarditisafterthepfizermessengerribonucleicacidcoronavirusdiseasevaccineinadolescents
AT colyerjessica myopericarditisafterthepfizermessengerribonucleicacidcoronavirusdiseasevaccineinadolescents
AT sagiveyal myopericarditisafterthepfizermessengerribonucleicacidcoronavirusdiseasevaccineinadolescents
AT lawyuk myopericarditisafterthepfizermessengerribonucleicacidcoronavirusdiseasevaccineinadolescents
AT mallenahallichikkabyrappasathish myopericarditisafterthepfizermessengerribonucleicacidcoronavirusdiseasevaccineinadolescents
AT portmanmichaela myopericarditisafterthepfizermessengerribonucleicacidcoronavirusdiseasevaccineinadolescents

Ejemplares similares